Currently, there are two main types of Food and Drug Administration (FDA)-approved drugs available for the treatment of AD: cholinesterase inhibitors and N-Methyl-D-aspartate receptor (NMDAR) antagonists [19]. The gene discussed is BCHE; the disease is Alzheimer disease.